| Date | Time | Source | Headline | Symbol | Company |
| 05/07/2024 | 12:51PM | iHub Newswire | FeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa | | |
| 08/25/2021 | 1:00PM | Business Wire | theScore Bet Becomes Official Gaming Partner of Golf Canada and its Marquee Golf Championships, the RBC Canadian Open and CP Women’s Open | NASDAQ:SCRX | Sciele Pharma (MM) |
| 08/19/2021 | 10:00AM | Business Wire | theScore Selects Toronto’s Waterfront Innovation Centre as Site for New, Expansive Headquarters | NASDAQ:SCRX | Sciele Pharma (MM) |
| 08/05/2021 | 7:01AM | Business Wire | Penn National Gaming to Acquire Score Media and Gaming, Creating North America’s Leading Digital Sports Content, Gaming and Technology Company | NASDAQ:SCRX | Sciele Pharma (MM) |
| 07/13/2021 | 5:01PM | Business Wire | theScore Reports F2021 Q3 Financial Results | NASDAQ:SCRX | Sciele Pharma (MM) |
| 07/06/2021 | 7:30AM | Business Wire | theScore to Report Q3 F2021 Financial Results on Tuesday, July 13, 2021 | NASDAQ:SCRX | Sciele Pharma (MM) |
| 06/22/2021 | 4:16PM | Business Wire | theScore Applauds Passage by the Senate of Historic Legislation to Legalize Single Event Sports Betting in Canada | NASDAQ:SCRX | Sciele Pharma (MM) |
| 04/22/2021 | 7:41PM | Business Wire | theScore Issues Statement Following the Passing of Bill C-218 by the House of Commons | NASDAQ:SCRX | Sciele Pharma (MM) |
| 04/13/2021 | 5:02PM | Business Wire | theScore Reports Record F2021 Q2 Financial Results | NASDAQ:SCRX | Sciele Pharma (MM) |
| 04/06/2021 | 7:45AM | Business Wire | theScore To Report Q2 F2021 Financial Results on Tuesday, April 13, 2021 | NASDAQ:SCRX | Sciele Pharma (MM) |
| 03/30/2021 | 1:02PM | Business Wire | PGA TOUR Announces theScore Bet as an Official Betting Operator | NASDAQ:SCRX | Sciele Pharma (MM) |
| 03/29/2021 | 8:30AM | Business Wire | theScore Secures Market Access for Mobile Sports Betting in Illinois Through Agreement with Caesars Entertainment | NASDAQ:SCRX | Sciele Pharma (MM) |
| 03/01/2021 | 11:04AM | Business Wire | theScore Announces Closing of US$186.3 Million Initial Public Offering in the United States | NASDAQ:SCRX | Sciele Pharma (MM) |
| 10/09/2008 | 5:01PM | Business Wire | Shionogi Completes Acquisition of Sciele | NASDAQ:SCRX | Sciele Pharma (MM) |
| 10/09/2008 | 11:10AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 10/09/2008 | 8:02AM | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 10/09/2008 | 7:30AM | Business Wire | Shionogi and Sciele Announce Completion of Subsequent Offering Period | NASDAQ:SCRX | Sciele Pharma (MM) |
| 10/06/2008 | 9:54AM | Edgar (US Regulatory) | Sciele Pharma, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 10/06/2008 | 6:30AM | Business Wire | Shionogi and Sciele Announce Successful Tender Offer and Commencement of Subsequent Offering | NASDAQ:SCRX | Sciele Pharma (MM) |
| 10/06/2008 | 6:05AM | Edgar (US Regulatory) | Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 10/01/2008 | 9:45AM | Edgar (US Regulatory) | Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/25/2008 | 7:38PM | PR Newswire (US) | Standard & Poor's Announces Update to the U.S. Market Cap Guidelines and Changes to U.S. Indices | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/19/2008 | 9:44AM | Edgar (US Regulatory) | Sciele Pharma, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/19/2008 | 6:08AM | Edgar (US Regulatory) | Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/19/2008 | 6:00AM | Business Wire | Shionogi and Sciele Announce Receipt of United States Antitrust Clearance | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/16/2008 | 9:46AM | Business Wire | Sciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe Drooling | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/08/2008 | 11:19AM | Edgar (US Regulatory) | Sciele Pharma, Inc. - Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/08/2008 | 11:03AM | Edgar (US Regulatory) | Sciele Pharma, Inc. - Tender offer statement by Third Party (SC TO-T) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/03/2008 | 4:49PM | Edgar (US Regulatory) | Sciele Pharma, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:SCRX | Sciele Pharma (MM) |
| 09/03/2008 | 4:47PM | Edgar (US Regulatory) | Sciele Pharma, Inc. - Current report filing (8-K) | NASDAQ:SCRX | Sciele Pharma (MM) |